Rhythm Pharmaceuticals Inc (RYTM)
63.98 +0.22 (+0.35%) 15:23 ET [NASDAQ]
63.89 x 9 63.98 x 1
Realtime by (Cboe BZX)
63.89 x 9 63.98 x 1
Realtime 63.90 +0.14 (+0.22%) 09:30 ET
for Mon, Apr 28th, 2025
Results
download Want to compare other data? Select Fields| Symbol | RYTM | RARE | SWTX | ||
| Company | Rhythm Pharmaceuticals Inc | Ultragenyx Pharmaceu | Springworks Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 63.92 | 38.40 | 46.12 | ||
| High | 64.65 | 38.90 | 46.20 | ||
| Low | 63.36 | 37.49 | 46.06 | ||
| Last | 63.98 | 37.85 | 46.16 | ||
| Change | +0.22 | -0.24 | +1.44 | ||
| % Change | +0.35% | -0.63% | +3.22% | ||
| Volume | 263,582 | 305,124 | 75,118,095 | ||
| 20-Day Average Volume | 996,798 | 1,032,164 | 6,501,751 | ||
| Previous Close | 63.76 | 38.09 | 44.72 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 57.87 | 35.03 | 40.04 | ||
| 20-Day Raw Stochastic | 95.73% | 88.61% | 94.44% | ||
| 20-Day Relative Strength | 60.99% | 51.68% | 54.70% | ||
| Weighted Alpha | +21.07 | -18.28 | -10.02 | ||
| Today's Opinion | 72% Buy | 80% Sell | 48% Buy | ||
| Previous Opinion | 72% Buy | 80% Sell | 40% Buy | ||
| Last Month's Opinion | 8% Sell | 100% Sell | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.57% since 04/21/25 | +6.89% since 04/21/25 | +24.57% since 04/21/25 | ||
| Low | 59.03 on 04/23/25 | 35.25 on 04/22/25 | 37.90 on 04/22/25 | ||
| High | 64.65 on 04/28/25 | 38.90 on 04/28/25 | 46.21 on 04/24/25 | ||
| 1-Month | |||||
| %Chg | +16.51% since 03/28/25 | +0.05% since 03/28/25 | -2.63% since 03/28/25 | ||
| Low | 45.90 on 04/07/25 | 29.59 on 04/09/25 | 32.83 on 04/09/25 | ||
| High | 64.65 on 04/28/25 | 38.90 on 04/28/25 | 46.95 on 04/02/25 | ||
| 3-Month | |||||
| %Chg | +12.39% since 01/28/25 | -10.94% since 01/28/25 | +28.63% since 01/28/25 | ||
| Low | 45.90 on 04/07/25 | 29.59 on 04/09/25 | 32.83 on 04/09/25 | ||
| High | 64.65 on 04/28/25 | 46.50 on 02/06/25 | 62.00 on 02/20/25 | ||
| 6-Month | |||||
| %Chg | +29.17% since 10/28/24 | -28.70% since 10/28/24 | +54.45% since 10/28/24 | ||
| Low | 45.90 on 04/07/25 | 29.59 on 04/09/25 | 29.25 on 10/29/24 | ||
| High | 68.58 on 11/11/24 | 53.48 on 10/29/24 | 62.00 on 02/20/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,968,367 | 3,044,950 | 2,931,125 | ||
| Shares Outstanding, K | 63,224 | 93,893 | 74,984 | ||
| Annual Sales | 130,130,000 | 560,230,000 | 191,590,000 | ||
| Annual Net Income | -260,600,000 | -569,180,000 | -258,130,000 | ||
| Last Quarter Sales | 41,830,000 | 164,880,000 | 61,550,000 | ||
| Last Quarter Net Income | -43,330,000 | -133,390,000 | -77,300,000 | ||
| 60-Month Beta | 2.32 | 0.61 | 0.79 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.72 on 02/26/25 | -1.39 on 02/13/25 | -1.04 on 02/20/25 | ||
| Latest Earnings Date | 05/07/25 | 05/01/25 | 05/01/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||